Mihael Hristos Polymeropoulos insider trades

Open-market stock purchases and sales by Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc, from SEC Form 4 filings since Jan 1, 2010.

Track record: 100% of 15 scored buys are up 5% or more since purchase, averaging +25%.

Recent trades

DateStockTradeValue
Mar 2, 2026VNDA Vanda Pharmaceuticals IncSold$1.3M
Feb 18, 2026VNDA Vanda Pharmaceuticals IncBought (not open market)—

Companies traded

  • VNDA Vanda Pharmaceuticals Inc: 15 buys, 39 sales, last Mar 2, 2026

Get free alerts when Mihael Hristos Polymeropoulos files a new trade →